Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Biochim Biophys Acta ; 1452(2): 121-32, 1999 Nov 11.
Article in English | MEDLINE | ID: mdl-10559465

ABSTRACT

To study the role of tyrosine phosphorylation in the control of intercellular adhesion of intestinal cells, we have generated several clones of Caco-2 cells that express high levels of pp60v-src only after addition of butyrate. Expression of this oncogene in cells 5 days after confluence induced beta-catenin and p120-ctn tyrosine phosphorylation, redistribution of E-cadherin to the cytosol and disassembly of adherens junctions. However, tight junctions of Caco-2 cells at 5 days after confluence were not altered by expression of pp60v-src. Similar results were obtained when Caco-2 cells were incubated with phosphotyrosine phosphatase inhibitor orthovanadate. Although addition of this compound to postconfluent cells disrupt adherens junctions, tight junctions remain unaltered, as determined measuring monolayer permeability to mannitol or hyperphosphorylation of Triton-insoluble occludin. Modifications in tight junction permeability of Caco-2 were only observed at high concentrations of orthovanadate (1 mM). Interestingly, this tyrosine phosphorylation-refractory state was achieved after confluence since early postconfluent cells (day 2) showed a limited but significant response to low doses of orthovanadate. These results suggest that tight junctions of differentiated Caco-2 cells are uncoupled from adherens junctions and are insensitive to regulation by tyrosine phosphorylation.


Subject(s)
Cell Adhesion Molecules/metabolism , Tight Junctions/metabolism , Tyrosine/metabolism , Caco-2 Cells , Cadherins/metabolism , Cytoskeletal Proteins/metabolism , Fluorescent Antibody Technique , Humans , Microscopy, Electron , Phosphorylation , Proto-Oncogene Proteins pp60(c-src)/genetics , Proto-Oncogene Proteins pp60(c-src)/metabolism , Transfection , Vanadates/pharmacology
2.
J Biol Chem ; 273(24): 15091-8, 1998 Jun 12.
Article in English | MEDLINE | ID: mdl-9614119

ABSTRACT

The phorbol ester phorbol 12-myristate 13-acetate induces remarkable phenotypic changes in intestinal HT-29 M6 cells; these changes consist of loss of homotypic adhesion and inactivation of E-cadherin. In parallel, cell growth is retarded. We have transfected HT-29 M6 cells with an activated form of the conventional protein kinase Calpha (cPK-Calpha). Expression of this isoform induced the acquisition of a scattered phenotype, similar to that adopted by cells after addition of phorbol 12-myristate 13-acetate, with very low cell-to-cell aggregation and undetectable levels of functional E-cadherin. These cell clones were highly motile and rapidly invaded embryonic chick heart fragments. Furthermore, cells expressing activated-cPK-Calpha showed decreased proliferation in comparison to control clones. We have also studied how these two apparently antagonistic changes affect the tumorigenic ability of HT-29 M6 cells. When the different cell clones were xenografted into athymic mice, the effect on cell growth seemed to predominate. Expression of activated-cPK-Calpha significantly reduced the size of the tumors; the cells with the highest level of expression did not even form subcutaneous tumors. Besides their smaller size, the morphology of these tumors was clearly different from those originated by HT-29 M6 cells, and they could be defined as infiltrative on anatomo-pathological basis. These results indicate that cPK-Calpha controls both cell-to-cell adhesion and proliferation of intestinal cells.


Subject(s)
Cell Adhesion/genetics , Cell Movement/genetics , Neoplasm Invasiveness/physiopathology , Protein Kinase C/physiology , Animals , Cadherins/analysis , Carbazoles/pharmacology , Cell Size/genetics , Gene Expression Regulation, Neoplastic/genetics , Humans , Indoles/pharmacology , Maleimides/pharmacology , Mice , Mice, Nude , Mutagenesis, Site-Directed/genetics , Neoplasms, Experimental/pathology , Protein Kinase C/genetics , Tetradecanoylphorbol Acetate/antagonists & inhibitors , Tetradecanoylphorbol Acetate/pharmacology , Transfection/genetics , Transplantation, Heterologous/pathology , Tumor Cells, Cultured , Urokinase-Type Plasminogen Activator/analysis
SELECTION OF CITATIONS
SEARCH DETAIL
...